Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.
Yang, Jinming
Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. [electronic resource] - Molecular cancer therapeutics Mar 2009 - 636-47 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
1535-7163
10.1158/1535-7163.MCT-08-0749 doi
Animals
Antineoplastic Agents--therapeutic use
Benzenesulfonates--administration & dosage
Biomarkers, Tumor--genetics
Dacarbazine--administration & dosage
Drug Delivery Systems--methods
Drug Synergism
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
Imidazoles--administration & dosage
Melanoma--drug therapy
Mice
Mice, Inbred BALB C
Mice, Nude
Models, Biological
Niacinamide--analogs & derivatives
Phenylurea Compounds
Pyridines--administration & dosage
Quinoxalines--administration & dosage
Skin Neoplasms--drug therapy
Sorafenib
Substrate Specificity
Temozolomide
Treatment Outcome
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. [electronic resource] - Molecular cancer therapeutics Mar 2009 - 636-47 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
1535-7163
10.1158/1535-7163.MCT-08-0749 doi
Animals
Antineoplastic Agents--therapeutic use
Benzenesulfonates--administration & dosage
Biomarkers, Tumor--genetics
Dacarbazine--administration & dosage
Drug Delivery Systems--methods
Drug Synergism
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
Imidazoles--administration & dosage
Melanoma--drug therapy
Mice
Mice, Inbred BALB C
Mice, Nude
Models, Biological
Niacinamide--analogs & derivatives
Phenylurea Compounds
Pyridines--administration & dosage
Quinoxalines--administration & dosage
Skin Neoplasms--drug therapy
Sorafenib
Substrate Specificity
Temozolomide
Treatment Outcome
Tumor Cells, Cultured
Xenograft Model Antitumor Assays